DELAHUNT GROUP, LLC for HEALIANCE PHARMACEUTICALS
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 11, 2014 | $50,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jan 9, 2015 | $50,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Foreign Relations FOR
Issues related to issuance of supplemental OFAC license.
Foreign entity interest: Foreign entity Digen Pharmaceuticals will benefit from work for client.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DELAHUNT | — |
| JOHN H. SUNUNU | — |
Pharmacy PHA
Issues related to issuance of supplemental OFAC license
Foreign entity interest: Foreign entity Digen Pharmaceuticals will benefit from work for client.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DELAHUNT | — |
| JOHN H. SUNUNU | — |
Health Issues HCR
Issues related to issuance of supplemental OFAC license
Foreign entity interest: Foreign entity Digen Pharmaceuticals will benefit from work for client.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DELAHUNT | — |
| JOHN H. SUNUNU | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.